Abstract
Background: Amphotericin B, designated as the gold standard among antifungal drugs is the only fungicidal effective against systemic fungal infections. But this drug has various pitfalls associated with it, to bypass which various techniques have been employed and resulted in a variety of lipid based commercially available formulations, which demolished only few of the shortcomings associated with this drug. Further, improvement in the delivery systems of Amphotericin B is advancing at increasingly frenetic pace, to surmount its research and to exploit its therapeutic potency with least toxicities.
Method: The patent search on “Amphotericin B for its safe and effective delivery” has been carried out to present assimilated information on the patents of the universally accepted Amphotericin B formulations and technologies. Also, the area of focus was the physicochemical properties of Amphotericin B, their role in formulation development and also nanotechnology based formulations of Amphotericin B. Results: Amphotericin B possesses poor aqueous solubility and systemic toxicity rendering obstacle in its formulation development. The interest of scientists and pharmaceutical industries to make further investments in the development of Amphotericin B formulations is due to rare occurrence of resistance to this drug. To bypass these drawbacks, various techniques have been patented which resulted in a variety of commercially available formulations to overcome the limitations of high cost, limited availability, poor storage stability and poor patient compliance. In lieu to this, scientists have developed and patented many novel drug delivery system based formulations and technologies such as use of novel carriers, modification in process for production and purification of Amphotericin B, formation of salts and complexes etc. to bring in limelight the benefits of this wonder drug. Conclusion: The purpose of the article is to present assimilated information regarding patents on Amphotericin B formulations and technologies.Keywords: Amphotericin B, antifungal activity, lipid-complexes, nanotechnology, NDDS, purification processes.
Graphical Abstract
Recent Patents on Nanotechnology
Title:Safe and Effective Delivery of Amphotericin B: A Survey of Patents
Volume: 11 Issue: 3
Author(s): Lakhvir Kaur, Abhijeet and Subheet K. Jain*
Affiliation:
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar-143005, Punjab,India
Keywords: Amphotericin B, antifungal activity, lipid-complexes, nanotechnology, NDDS, purification processes.
Abstract: Background: Amphotericin B, designated as the gold standard among antifungal drugs is the only fungicidal effective against systemic fungal infections. But this drug has various pitfalls associated with it, to bypass which various techniques have been employed and resulted in a variety of lipid based commercially available formulations, which demolished only few of the shortcomings associated with this drug. Further, improvement in the delivery systems of Amphotericin B is advancing at increasingly frenetic pace, to surmount its research and to exploit its therapeutic potency with least toxicities.
Method: The patent search on “Amphotericin B for its safe and effective delivery” has been carried out to present assimilated information on the patents of the universally accepted Amphotericin B formulations and technologies. Also, the area of focus was the physicochemical properties of Amphotericin B, their role in formulation development and also nanotechnology based formulations of Amphotericin B. Results: Amphotericin B possesses poor aqueous solubility and systemic toxicity rendering obstacle in its formulation development. The interest of scientists and pharmaceutical industries to make further investments in the development of Amphotericin B formulations is due to rare occurrence of resistance to this drug. To bypass these drawbacks, various techniques have been patented which resulted in a variety of commercially available formulations to overcome the limitations of high cost, limited availability, poor storage stability and poor patient compliance. In lieu to this, scientists have developed and patented many novel drug delivery system based formulations and technologies such as use of novel carriers, modification in process for production and purification of Amphotericin B, formation of salts and complexes etc. to bring in limelight the benefits of this wonder drug. Conclusion: The purpose of the article is to present assimilated information regarding patents on Amphotericin B formulations and technologies.Export Options
About this article
Cite this article as:
Kaur Lakhvir, Abhijeet and Jain K. Subheet*, Safe and Effective Delivery of Amphotericin B: A Survey of Patents, Recent Patents on Nanotechnology 2017; 11 (3) . https://dx.doi.org/10.2174/1872210511666170105130210
DOI https://dx.doi.org/10.2174/1872210511666170105130210 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hybrid Stress Testing by Adenosine Infusion and Exercise Myocardial Perfusion Imaging: A Critical Appraisal
Current Cardiology Reviews Hydrogen Sulfide: From Physiology to Pharmacology
Inflammation & Allergy - Drug Targets (Discontinued) The Reno-Protective Effect of the Dual Blockade of the Renin Angiotensin System (RAS)
Current Pharmaceutical Design Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Platelet Aggregation and Exogenous Factors From Animal Sources
Current Drug Targets - Cardiovascular & Hematological Disorders Management of Postoperative Nausea and Vomiting in Women Undergoing Major Gynecological Surgery: A Review and Update
Current Drug Therapy Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone
Current Pharmaceutical Design Monobactams: A Unique Natural Scaffold of Four-Membered Ring Skeleton, Recent Development to Clinically Overcome Infections by Multidrug- Resistant Microbes
Letters in Drug Design & Discovery Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Current Pharmaceutical Design Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Diagnosing and Treating Depression in Older and Oldest Old
Current Pharmaceutical Design Neurotoxicity of Insecticides
Current Medicinal Chemistry Binary Actin-ADP-Ribosylating Toxins and their Use as Molecular Trojan Horses for Drug Delivery into Eukaryotic Cells
Current Medicinal Chemistry Reduction of Sympathetic Hyperactivity by Agents that Inhibit the Renin Angiotensin Aldosterone System
Current Hypertension Reviews Microdialysis in Drug Discovery
Current Drug Discovery Technologies Immunotherapy of Kidney Cancer
Current Clinical Pharmacology Identification of Bioactive Natural Products by Pharmacophore-Based Virtual Screening
Current Pharmaceutical Design Diterpenes: A Therapeutic Promise for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Contribution of MEK1/ERK1/2/iNOS Pathway to Oxidative Stress and Decreased Caspase-3 Activity in Endotoxemic Rats
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry